Shouyao Holdings (Beijing)Co.

BiotechnologySeries ABeijing, Chinashouyaoholding.com

Latest round

Series A

Last raised

Jul 2019

Total raised

$29M

Investors

1

About Shouyao Holdings (Beijing)Co.

, LTD previously known as Shouyao Holdings is a biotechnology company that focused on the development and production of new drugs for cancer and diabetes. The company has a full process innovative drug R&D system integrating drug design, target biology, clinical medicine, and translational medicine. The company has 159 invention patents and 22 pipelines of new drugs under investigation. In March 2022, the company was listed on Shanghai Stock Exchange under the number 688197. The company provides small molecule new drugs for cancer and diabetes. Specific drugs pipeline include SY-707, SY-1530, SY-3505, SY-5007, SY-4835. The SY-707 is an Anaplastic lymphoma kinase inhibitor cured for lung cancer, which is in phase II clinical trials. SY-1530 is in phase II clinical trials for lymphoma indication. SY-707, SY-1530 have been supported by the projects of Major New Drug Creation. SY-5007 is RE arranged during Transfection (RET)inhibitor. SY-4835 is a Wee1 inhibitor. As of March 2022, the company developed drugs all in clinical trials, not in the listing.

Who invested in Shouyao Holdings (Beijing)Co.

1 investor across 1 round

See all investors in Shouyao Holdings (Beijing)Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jul 9, 2019

    Amount

    $29M

    Investors

    Locked

Questions about Shouyao Holdings (Beijing)Co.

Who invested in Shouyao Holdings (Beijing)Co.?

Shouyao Holdings (Beijing)Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Shouyao Holdings (Beijing)Co. raised?

Shouyao Holdings (Beijing)Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Shouyao Holdings (Beijing)Co. last raise money?

Shouyao Holdings (Beijing)Co.'s most recent round on record is a Series A, in Jul 2019.

What does Shouyao Holdings (Beijing)Co. do?

, LTD previously known as Shouyao Holdings is a biotechnology company that focused on the development and production of new drugs for cancer and diabetes.

Where is Shouyao Holdings (Beijing)Co. headquartered?

Shouyao Holdings (Beijing)Co. is headquartered in Beijing, China.

Which VCs invest in companies like Shouyao Holdings (Beijing)Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shouyao Holdings (Beijing)Co.'s stage. Their profiles are linked below.

Raising like Shouyao Holdings (Beijing)Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.